Skip to main content
OpenTrials
Completed

NCT Number: NCT02960841

Effectiveness of Intracavitary Manual Lymphatic Drainage

The aim of this study was to determine the effectiveness of Intracavitary Manual Lymphatic Drainage (IMLD) in the reduction of the perineal trauma and the symptoms of vaginal edema, the prevention of complications during the expulsive and the improvement in the postpartum recovery, compared to conventional treatment during the gestation, in women with the second partum. The weekly treatment is performed from the 25th gestational week in women with vulvar edema.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A sample of 49 second-trimester pregnant women with gestational edema with more than 18 years of age

Exclusion criteria

  • Primiparous women

Treatment and study plan

Intracavitary Manual Lymphatic Drainage

Other

conventional treatment

Other

Primary outcomes

  1. Pain intensity assessed by the Visual Analogue Scale

    Time frame: 5 weeks

Sponsors and collaborators

Lead sponsor

Universidad Europea de Madrid

Other

Registry information

Official study title

Effectiveness of Intracavitary Manual Lymphatic Drainage Versus Conventional Treatment in the Prevention of Perineal Trauma During Labor.

Acronym: IMLD

Important dates

Study start
2012
Primary completion
2016
Study completion
2016
First posted
Nov 10, 2016
Registry last updated
Sep 23, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.